From sweeping drug price reforms to proposed staffing mandates and changes to Medicaid financing, here are five federal policy moves from the last week that ASCs need to know: CMS proposes updates for ...

What a pity that a Republican administration needs to be reminded that this misguided policy won’t make America healthy or ...

Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down as the Danish drug giant faces increased competition for its ...

This month, the Centers for Medicare and Medicaid Services will begin meeting with patients who use the 15 drugs it selected ...

For decades, Americans have been overpaying for prescriptions and subsidizing innovation for the rest of the world. The White ...

Pharmacy benefit managers face new compensation restrictions and transparency rules from the sweeping reconciliation budget ...

Americans spend more on prescription and over-the-counter drugs than anyone else in the world. It’s true that they take a lot ...

Emphasizes that the United States aims to provide access to prescription drugs at lower costs for US patients and taxpayers, ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

The EO states that while American citizens represent only 5% of the global population, they fund around 75% of global ...

President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture ...